These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26438094)

  • 1. [Molecular ultrasound imaging: Clinical applications].
    Rix A; Palmowski M; Kiessling F
    Radiologe; 2015 Nov; 55(11):956-63. PubMed ID: 26438094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Ultrasound Imaging.
    Baier J; Rix A; Kiessling F
    Recent Results Cancer Res; 2020; 216():509-531. PubMed ID: 32594397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound molecular imaging: Moving toward clinical translation.
    Abou-Elkacem L; Bachawal SV; Willmann JK
    Eur J Radiol; 2015 Sep; 84(9):1685-93. PubMed ID: 25851932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
    Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
    Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study.
    Smeenge M; Tranquart F; Mannaerts CK; de Reijke TM; van de Vijver MJ; Laguna MP; Pochon S; de la Rosette JJMCH; Wijkstra H
    Invest Radiol; 2017 Jul; 52(7):419-427. PubMed ID: 28257340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55.
    Hackl C; Schacherer D; Anders M; Wiedemann LM; Mohr A; Schlitt HJ; Stroszczynski C; Tranquart F; Jung EM
    Ultraschall Med; 2016 Jun; 37(3):290-6. PubMed ID: 27112624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
    Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
    Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin.
    Leguerney I; Scoazec JY; Gadot N; Robin N; Pénault-Llorca F; Victorin S; Lassau N
    Ultrasound Med Biol; 2015 Jan; 41(1):197-207. PubMed ID: 25308938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional ultrasound imaging of breast tumors.
    Bzyl J; Lederle W; Palmowski M; Kiessling F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S11-2. PubMed ID: 23083550
    [No Abstract]   [Full Text] [Related]  

  • 15. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
    Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
    Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent.
    Frinking PJ; Tardy I; Théraulaz M; Arditi M; Powers J; Pochon S; Tranquart F
    Ultrasound Med Biol; 2012 Aug; 38(8):1460-9. PubMed ID: 22579540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrasound contrast agents for liver diagnostics].
    Lemke AJ; Chopra SS; Niehues SM; Felix R
    Radiologe; 2005 Jun; 45(6):520-8. PubMed ID: 15912323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
    Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
    Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound contrast media--principles and clinical applications].
    Delorme S; Krix M; Albrecht T
    Rofo; 2006 Feb; 178(2):155-64. PubMed ID: 16435246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular imaging in oncology using targeted ultrasound contrast agents].
    Palmowski M; Palmowski M; Hauff P; Kiessling F
    Praxis (Bern 1994); 2009 May; 98(11):597-602. PubMed ID: 19472145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.